Literature DB >> 15640547

Endocrine tumor syndromes in infancy and childhood.

Ronald R de Krijger1.   

Abstract

Of endocrine disorders that present in the pediatric age range, three heritable tumor syndromes have received a large amount of attention over the past decade, because the relevant genes have been discovered and we have begun to understand the role of some of the proteins involved. In this short review article, the dominantly inherited tumor syndromes multiple endocrine neoplasia type 1 (MEN1), caused by mutations in the menin gene, type 2 (MEN2), caused by mutations in the RET protooncogene, and von Hippel-Lindau disease (VHL), caused by VHL gene abnormalities including mutations, are discussed with an emphasis on the age and mode of presentation of the constituent tumors. Also, current screening and/or treatment guidelines are included.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15640547     DOI: 10.1385/ep:15:3:223

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  16 in total

Review 1.  Clinical review 155: Pheochromocytoma in Von Hippel-Lindau disease.

Authors:  Frederik J Hes; Jo W M Höppener; Cornelis J M Lips
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

Review 2.  Investigating familial endocrine neoplasia syndromes in children.

Authors:  L B Johnston; S L Chew; D Lowe; R Reznek; J P Monson; M O Savage
Journal:  Horm Res       Date:  2001

3.  Study of a kindred with pheochromocytoma, medullary thyroid carcinoma, hyperparathyroidism and Cushing's disease: multiple endocrine neoplasia, type 2.

Authors:  A L Steiner; A D Goodman; S R Powers
Journal:  Medicine (Baltimore)       Date:  1968-09       Impact factor: 1.889

Review 4.  Von Hippel-Lindau disease: strategies in early detection (renal-, adrenal-, pancreatic masses).

Authors:  F J Hes; M A Feldberg
Journal:  Eur Radiol       Date:  1999       Impact factor: 5.315

5.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.

Authors:  P H Maxwell; M S Wiesener; G W Chang; S C Clifford; E C Vaux; M E Cockman; C C Wykoff; C W Pugh; E R Maher; P J Ratcliffe
Journal:  Nature       Date:  1999-05-20       Impact factor: 49.962

Review 6.  von Hippel-Lindau disease.

Authors:  E R Maher; W G Kaelin
Journal:  Medicine (Baltimore)       Date:  1997-11       Impact factor: 1.889

7.  Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function.

Authors:  C E Stebbins; W G Kaelin; N P Pavletich
Journal:  Science       Date:  1999-04-16       Impact factor: 47.728

Review 8.  Multiple endocrine neoplasia type 1: fresh perspective on clinical features and penetrance.

Authors:  Matthew J Glascock; Sally E Carty
Journal:  Surg Oncol       Date:  2002-11       Impact factor: 3.279

9.  Review of multiple endocrine neoplasia type 2A in children: therapeutic results of early thyroidectomy and prognostic value of codon analysis.

Authors:  Gabor Szinnai; Christian Meier; Paul Komminoth; Urs W Zumsteg
Journal:  Pediatrics       Date:  2003-02       Impact factor: 7.124

10.  Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.

Authors:  M A Skinner; M K DeBenedetti; J F Moley; J A Norton; S A Wells
Journal:  J Pediatr Surg       Date:  1996-01       Impact factor: 2.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.